The historical rank and industry rank for Relay Therapeutics's Pretax Margin % or its related term are showing as below:
RLAY'
s Pretax Margin % Range Over the Past 10 Years
Min: -21036.13 Med: -6675.8 Max: -63.41
Current: -931.64
RLAY's Pretax Margin % is ranked worse than 72.37% of 1028
companies
in the Biotechnology industry
Industry Median: -155.98
vs RLAY: -931.64
Relay Therapeutics Pretax Margin % Historical Data
The historical data trend for Relay Therapeutics's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Relay Therapeutics's Pretax Margin %
For the Biotechnology subindustry, Relay Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Relay Therapeutics's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Relay Therapeutics's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Relay Therapeutics's Pretax Margin % falls into.
Relay Therapeutics Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Relay Therapeutics's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Relay Therapeutics Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Relay Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Relay Therapeutics (Relay Therapeutics) Business Description
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RLAY has been successfully added to your 